about
Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerationsDrug Therapy in the Progressed CML Patient with multi-TKI FailureInduction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells.First-line treatment of newly diagnosed elderly patients with chronic myeloid leukemia: current and emerging strategies.Update on emerging treatments for chronic myeloid leukemia.Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison.Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting.Response to tyrosine kinase inhibitors in chronic myeloid leukemia: experience from a west Asian developing country.
P2860
Q27004032-CECEA96B-68EA-42F1-BBAD-B9BA94CE63B0Q28085353-3ABAEB6A-F5F1-468F-BEA6-6825D038DDF5Q35608071-CC8A5D3B-8C55-4A53-9738-607FA0892601Q38202913-59C99B20-FBC1-47C8-97C8-F22562036715Q38397515-F2FD78A5-246A-47C5-93B6-935CA865DD28Q38604104-79566DC5-F7E0-41B2-9B70-F3C856A9FD65Q39637488-54043D77-F0CE-42FF-9586-33A8DB1910D3Q54333450-16E1BD35-5027-4FAF-BB5D-5496ACC5FCC4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment recommendations for chronic myeloid leukemia
@en
type
label
Treatment recommendations for chronic myeloid leukemia
@en
prefLabel
Treatment recommendations for chronic myeloid leukemia
@en
P2860
P50
P356
P1476
Treatment recommendations for chronic myeloid leukemia
@en
P2860
P304
P356
10.4084/MJHID.2014.005
P577
2014-01-02T00:00:00Z